Literature DB >> 20585954

Huntington's disease: changes in saccades and hand-tapping over 3 years.

Chrystalina A Antoniades1, Zheyu Xu, Sarah L Mason, R H S Carpenter, Roger A Barker.   

Abstract

Saccades and hand-tapping are both potential biomarkers in patients with Huntington's disease (HD). While it is well known that patients with manifest Huntington's disease display abnormalities in both of these tasks, less is known about how these abnormalities progress over time, or to what extent premanifest patients are affected. This study was designed to address these issues. We examined premanifest and manifest Huntington's cohorts, together with a group of controls, over a 3-year period. Data were collected using a portable head-mounted saccadometer and a computerised hand-tapping device. Both premanifest and manifest Huntington's disease patients display significant and systematic changes from year to year in the parameters describing saccadic latency, while controls remain unchanged. By contrast, although hand-tapping was abnormal in HD patients, annual changes were much smaller. Measuring the rate of progression of saccadic abnormalities in manifest HD patients may provide a way to track disease progression, and thus help to evaluate novel therapies to modify the disease. The clear-cut progression in saccadic abnormalities in the premanifest group may prove useful in the future as a predictor of time to disease onset.

Entities:  

Mesh:

Year:  2010        PMID: 20585954     DOI: 10.1007/s00415-010-5632-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

Review 1.  Role of the basal ganglia in the control of purposive saccadic eye movements.

Authors:  O Hikosaka; Y Takikawa; R Kawagoe
Journal:  Physiol Rev       Date:  2000-07       Impact factor: 37.312

2.  Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease.

Authors:  T M Blekher; R D Yee; S C Kirkwood; A M Hake; J C Stout; M R Weaver; T M Foroud
Journal:  Vision Res       Date:  2004-10       Impact factor: 1.886

3.  Lifespan development of pro- and anti-saccades: multiple regression models for point estimates.

Authors:  Christoph Klein; Friedrich Foerster; Klaus Hartnegg; Burkhart Fischer
Journal:  Brain Res Dev Brain Res       Date:  2005-11-02

4.  Visual attention in Huntington's disease: the effect of cueing on saccade latencies and manual reaction times.

Authors:  T T Tsai; A Lasker; D S Zee
Journal:  Neuropsychologia       Date:  1995-12       Impact factor: 3.139

5.  Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.

Authors:  Alexander Peinemann; Sabine Schuller; Córina Pohl; Thomas Jahn; Adolf Weindl; Jan Kassubek
Journal:  J Neurol Sci       Date:  2005-09-26       Impact factor: 3.181

6.  A disorder of rapid eye movements in Huntington's chorea.

Authors:  A Starr
Journal:  Brain       Date:  1967-09       Impact factor: 13.501

7.  The use of quantitative oculometry in the assessment of Huntington's disease.

Authors:  F R Ali; A W Michell; R A Barker; R H S Carpenter
Journal:  Exp Brain Res       Date:  2005-11-05       Impact factor: 1.972

8.  Oculomotor deficits indicate the progression of Huntington's disease.

Authors:  Stephen L Hicks; Matthieu P A Robert; Charlotte V P Golding; Sarah J Tabrizi; Christopher Kennard
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

9.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

10.  Profile of cognitive progression in early Huntington's disease.

Authors:  A K Ho; B J Sahakian; R G Brown; R A Barker; J R Hodges; M-N Ané; J Snowden; J Thompson; T Esmonde; R Gentry; J W Moore; T Bodner
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910

View more
  19 in total

1.  Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression.

Authors:  Saumil S Patel; Joseph Jankovic; Ashley J Hood; Cameron B Jeter; Anne B Sereno
Journal:  J Neurol Sci       Date:  2011-10-21       Impact factor: 3.181

2.  Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study.

Authors:  Jürgen Keller; Martin Gorges; Hannah T Horn; Helena E A Aho-Özhan; Elmar H Pinkhardt; Ingo Uttner; Jan Kassubek; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

3.  Movement sequencing in Huntington disease.

Authors:  Nellie Georgiou-Karistianis; Jeffrey D Long; Spencer G Lourens; Julie C Stout; James A Mills; Jane S Paulsen
Journal:  World J Biol Psychiatry       Date:  2014-03-28       Impact factor: 4.132

4.  Using saccades to diagnose covert hepatic encephalopathy.

Authors:  Nicholas Cunniffe; Henry Munby; Shona Chan; Defne Saatci; Eric Edison; R H S Carpenter; Dunecan Massey
Journal:  Metab Brain Dis       Date:  2015-01-15       Impact factor: 3.584

5.  Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease.

Authors:  Jason Rupp; Mario Dzemidzic; Tanya Blekher; John West; Siu Hui; Joanne Wojcieszek; Andrew J Saykin; David A Kareken; Tatiana Foroud
Journal:  J Neurol       Date:  2011-08-18       Impact factor: 4.849

6.  Impact of Huntington's Disease on Mental Rotation Performance in Motor Pre-Symptomatic Individuals.

Authors:  Shahin Nasr; Herminia D Rosas
Journal:  J Huntingtons Dis       Date:  2019

Review 7.  Ocular motor abnormalities in neurodegenerative disorders.

Authors:  C A Antoniades; C Kennard
Journal:  Eye (Lond)       Date:  2014-11-21       Impact factor: 3.775

8.  Behavioral measures of saccade latency and inhibition in manifest and premanifest Huntington's disease.

Authors:  Travis H Turner; Jody Goldstein; Joanne M Hamilton; Mark Jacobson; Eva Pirogovsky; Guerry Peavy; Jody Corey-Bloom
Journal:  J Mot Behav       Date:  2011-06-24       Impact factor: 1.328

Review 9.  Eye movements in patients with neurodegenerative disorders.

Authors:  Tim J Anderson; Michael R MacAskill
Journal:  Nat Rev Neurol       Date:  2013-01-22       Impact factor: 42.937

10.  Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function.

Authors:  Chrystalina A Antoniades; James J FitzGerald
Journal:  J Vis Exp       Date:  2016-07-14       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.